01036nam2 22002653i 450 PAV006306920231121125606.0978885980841120160114d2012 ||||0itac50 baitaitz01i xxxe z01nAggiornamento [5]TorinoUtet2012XVIII, 740 p.25 cm001CFI00623202001 Digesto delle discipline pubblicistichediritto costituzionale, diritto amministrativo, diritto regionale, diritto internazionale, diritto comunitario, diritto ecclesiastico, diritto canonico, diritto pubblico comparatoITIT-0120160114IT-FR0098 Biblioteca Area Giuridico EconomicaFR0098 PAV0063069Biblioteca Area Giuridico Economica 53DEG UT 11 Agg. 5 53DEG0000005065 VMN B 2016011420160114 53Aggiornamento63262UNICAS02557oas 2200793 a 450 991069343760332120250713213019.0(OCoLC)173251447(CONSER) 2008243059(CKB)2320000000018060(EXLCZ)99232000000001806020070923b20072009 ua aengur|||||||||||txtrdacontentcrdamediacrrdacarrierDrug safety newsletter[Bethesda, Md.] Food and Drug Administration, Center for Drug Evaluation and Research1 online resource (7 volumes)2156-9967 "The Drug Safety Newsletter is a source of information for healthcare professionals about the findings of selected postmarketing drug safety issues from FDA's Center for Drug Evaluation and Research (CDER). ..."FDA drug safety newsletterDrug interactionsUnited StatesPeriodicalsDrugsToxicologyUnited StatesPeriodicalsDrug-Related Side Effects and Adverse ReactionsDrug InteractionsInteractions médicamenteusesÉtats-UnisPériodiquesMédicamentsToxicologieÉtats-UnisPériodiquesDrug interactionsfast(OCoLC)fst00898681DrugsToxicologyfast(OCoLC)fst00898958United Statesfasthttps://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrqPeriodical.Periodicals.fastPeriodicals.lcgftDrug interactionsDrugsToxicologyDrug-Related Side Effects and Adverse Reactions.Drug Interactions.Interactions médicamenteusesMédicamentsToxicologieDrug interactions.DrugsToxicology.363Center for Drug Evaluation and Research (U.S.)USUUSUUSUNLMGPODLCGPOOCLCQOCLCOOCLCFDLCOCLCQGILDSOCLCQGPOOCLCOOCLCQOCLCLMLUOCLCLJOURNAL9910693437603321Drug safety newsletter3204995UNINA